- Conference Call and Webcast to Follow -
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Apr. 21, 2014--
Exelixis, Inc. (NASDAQ: EXEL) will release its first quarter 2014
financial results on Thursday, May 1, 2014 after the markets close. The
announcement will be followed by a live conference call and webcast at
5:00 p.m. EDT/ 2:00 p.m. PDT. During the presentation, Exelixis
management will discuss the Company's financial results and provide a
general business update.
The conference call will be webcast live and may be accessed in the
Event Calendar page under Investors & Media at www.exelixis.com.
Please connect to the company’s website at least 15 minutes prior to the
conference call to ensure adequate time for any software download that
may be required to listen to the webcast. Alternatively, please call
1-866-202-3048 (domestic) or 1-617-213-8843 (international) and provide
the conference call passcode 28848437 to join by phone.
A telephone replay will be available until 11:59 p.m. PDT on June 1,
2014. Access numbers for the phone replay are: 888-286-8010 (domestic)
and 617-801-6888 (international); the passcode is 74388407. A webcast
replay will also be archived on www.exelixis.com
for 30 days.
About Exelixis
Exelixis is a biotechnology company committed to developing small
molecule therapies for the treatment of cancer. Exelixis is focusing its
proprietary resources and development efforts exclusively on COMETRIQ®
(cabozantinib). Exelixis has also established a portfolio of other novel
compounds that it believes have the potential to address serious unmet
medical needs, many of which are being advanced by partners as part of
collaborations. For more information, please visit the company's web
site at www.exelixis.com.
Exelixis, the Exelixis logo, and COMETRIQ are registered U.S.
trademarks.
Source: Exelixis, Inc.
Exelixis, Inc.
Susan Hubbard, 650-837-8194
Investor Relations
and Corporate Communications
shubbard@exelixis.com
